Summary
It has been suggested that drugs block the effects of serotonin (5-HT) in the brain based on (1) the ability to block the effects of 5-HT on smooth muscle and on invertebrate neurons (e.g., cinanserin, cyproheptadine, methysergide [UML], and metergoline [MCE]) and (2) the ability to block certain gross electrophysiological effects of 5-hydroxytryptophan (e.g., methiothepin). Although these “antagonists” are often assumed to block all 5-HT receptors in the CNS, the ability of these drugs to block 5-HT at documented 5-HT synapses in the brain has not been thoroughly tested. Since 5-HT may produce either excitation or inhibition, these antagonists were evaluated with respect to both types of responses. Only inhibition is produced by 5-HT on cells in areas receiving a heavy serotonergic input (e.g., ventral lateral geniculate, optic tectum and amygdala) as determined by fluorescent histochemistry. Raphe cells, virtually the only 5-HT-containing neurons in the CNS, are also inhibited by 5-HT. Cells in the reticular formation, an area which receives little or no 5-HT input may be either excited or inhibited by 5-HT. The five putative antagonists do not block the inhibitory response to 5-HT in any of these areas. The excitatory response to 5-HT in the reticular formation can be blocked by the putative antagonists. However, the failure of these compounds to block 5-HT in any of the three areas tested that receive a heavy serotonergic input casts doubt on the assumption that any one of these compounds is a universal central 5-HT antagonist.
Similar content being viewed by others
References
Aghajanian, G. K., H. J. Haigler, andF. E. Bloom: Lysergic acid diethylamide and serotonin: Direct actions on serotonin-containing neurons. Life Sci.11, 615–622 (1972).
Aghajanian, G. K., H. J. Haigler, andJ. L. Bennett: Amine receptors in brain. III: 5-hydroxytryptamine. In: Handbook of Psychopharmacology (Iverson, L. L., S. D. Iverson, andS. H. Snyder, eds.). New York: Plenum Press. In press (1974).
Aghajanian, G. K., M. J. Kuhar, andR. H. Roth: Serotonin-containing neuronal perikarya and terminals: differential effects of p-chlorophenylalanine. Brain Res.54, 85–101 (1973).
Baldrati, G., G. Arcari, andG. K. Suchowsky: Studies on a compound antagonistic to 5-hydroxytryptamine. Experientia21, 396–399 (1965).
Banna, N. R., andE. G. Anderson: The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity. J. Pharmacol. Exp. Therap.162, 319–325 (1968).
Beretta, C., A. H. Glässer, M. B. Nobili, andR. Silverstri: Antagonism of 5-hydroxytryptamine—induced bromchospasm in guinea-pigs by 8 B-carbobenzyloxyaminomethyl-l-dimethyl-l0-ergoline. J. Pharm. Pharmacol.17, 423–428 (1965).
Bloom, F. E., B. J. Hoffer, G. R. Siggins, J. L. Barker, andR. A. Nicoll: Effects of serotonin on central neurons. Microiontophoretic administration. Fed. Proc.31, 97–106 (1972).
Bloom, F. E., B. J. Hoffer, C. Nelson, Y. Sheu, andG. R. Siggins: The physiology and pharmacology of serotonin mediated synapses. In: Serotonin and Behavior (Barchas, J., andE. Usdin, eds.), pp. 249–261. New York: Academic Press. 1973.
Boakes, R. J., P. B. Bradley, I. Briggs, andA. Dray: Antagonism of 5-hydroxytryptamine by LSD-25 in the central nervous system: A possible neuronal basis for the actions of LSD-25. Brit. J. Pharmacol.40, 202 to 218 (1970).
Bradley, P. B., andJ. H. WolstencrofT: Actions of drugs on single neurons in the brainstem. Br. Med. Bull.21, 15–18 (1965).
Chakrabarty, A. S., R. V. Pillai, B. K. Anand, andB. Singb: Effect of cyproheptadine on the electrical activity of the hypothalamic feeding centres. Brain Res.6, 561–569 (1967).
Clineschmidt, B. V., andE. G. Anderson: The blockade of bulbospinal inhibition by 5-hydroxytryptamine. Exp. Brain Res.11, 175–186 (1970).
Cottrell, G. A.: Direct post-synaptic responses to stimulation of serotonin-containing neurons. Nature225, 1060–1062 (1970).
Curtis, D. R., andR. Davis: Pharmacological studies upon neurones of the lateral geniculate nucleus of the cat. Brit. J. Pharmacol.18, 217–246 (1962).
Curtis, D. R., J. W. Phillis, andJ. C. Watkins: Cholinergic and non-cholinergic transmission in the mammalian spinal cord. J. Physiol. (London)158, 296–323 (1961).
Dahlström, A., andK. Fuxe: Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monosamines in the cell bodies of brain stem neurons. Acta Physiol. Scand.62, Suppl. 232, 1–55 (1965).
Fanchamps, A., W. Doepfner, H. Weidmann, andA. Cerletti: Pharmakologische Charakterisierung von Deseril (R), einem Serotonin-Antagonisten. Schweiz. Med. Wschr.90, 1040–1046 (1960).
Frederickson, R. C. A., S. M. Jordan. andJ. W. Phillis: A reappraisal of the actions of noradrenaline and 5-hydroxytryptamine on cerebral cortical neurons. Comp. gen Pharmac.3, 443–456 (1972).
Furgiuele, A. R., J. P. High, andZ. P. Horovitz: Some central effects of SQ 10, 643 [2′3-(dimethylaminopropylthio) cinnamanilide hydrochloride], a potent serotonin antagonist. Arch. Int. Pharmacodyn.155, 225–235 (1965).
Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol. Scand.64, Suppl. 247, 39–85 (1965).
Gyermek, L.: 5-hydroxytryptamine antagonists. Pharmacol. Rev.13, 399 to 439 (1961).
Haigler, H. J., andG. K. Aghajanian: Mescaline and LSD: Direct and indirect effects on serotonin-containing neurons in brain. Eur. J. Pharmacol.21, 53–60 (1973).
Haigler, H. J., andG. K. Aghajanian: Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. J. Pharmacol. Exp. Therap.188, 688 to 699 (1974).
Jordan, L. M., R. C. A. Frederickson, J. W. Phillis, andN. Lake: Microiontophoresis of 5-hydroxytryptamine: a clarification of its action on cerebral cortical neurones. Brain Res.40, 552–558 (1972).
Karja, J., N. T. Karki, andE. Tala: Inhibition by methysergide of 5-hydroxytryptophan toxicity to mice. Acta. Pharmacol. (Kobenhavn)18, 255–262 (1961).
Keller, H. H., G. Bartholini, andA. Pletscher: Increase of 3-methoxy-4hydroxyphenylethylene glycol in rat brain by neuroleptic drugs. Eur. J. of Pharmacol.23, 183–186 (1973).
Krnjevic, K., andJ. W. Phillis: Actions of certain amines on cerebral cortical neurons. Brit. J. Pharmacol. Chemother.20, 471–490 (1963).
Kuhar, M. J., G. K. Aghajanian, andR. H. Roth: Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence. Brain Res.44, 165–176 (1972).
Monachon, M. A., W. P. Burkard, M. Jalfre, andW. Haefely: Blockade of central 5-hydroxytryptamine receptors by methiothepin. Naunyn-Schmiedeberg's Arch. Pharmacol.247, 192–197 (1972).
Narebski, J., W. Romanowski, andW. Kadziela: The influence of 1-methyld-lysergic butanolamide (Deseril) on EEG changes in rabbits caused by 5-hydroxytryptamine. Acta Physiol. Pol.14, 154–170 (1963).
Persip, G. L., andL. W. Hamilton: Behavioral effects of serotonin or a blocking agent applied to the septum of the rat. Pharmacol. Biochem. Behav.1, 139–147 (1973).
Reizen, H. van: Different central effects of the 5-HT antagonists mianserine and cyproheptadine. Arch. Int. Pharmacodyn. Ther.198, 256–269 (1972).
Roberts, M. H. T., andD. W. Straughan: Excitation and depression of cortical neurons by 5-hydroxytryptamine. J. Physiol.193, 269–294 (1969).
Rubin, B. J., J. Piala, J. C. Burke, andB. N. Craver: A new and specific serotonin inhibitor, (SQ 10, 643) 2′ (3-dimethylaminopropylthio) cinnamanlide hydrochloride: Antiserotonin activity on uterus and on gastro intestinal, vascular and respiratory systems of animals. Arch. Int. Pharmacodyn. Ther.152, 132–143 (1964).
Salmoiraghi, G. C., andF. Weight: Micromethods in neuropharmacology: An approach to the study of anesthesia. Anesthesiology28, 54–64 (1967).
Sclafani, A., andS. P. Grossman: Hyperphagia produced by knife cuts between the medial and lateral hypothalamus in the rat. Physiol. and Behavior4, 533–537 (1969).
Segal, M., andF. E. Bloom: The projection of midline raphe nuclei to the hippocampus of the rat. Federation Proceedings 331, abstract 538 (1974).
Stone, S. A., H. C. Wenger, C. T. Ludden, J. M. Stavorski, andC. A. Ross: Antiserotonin-antihistaminic properties of cyproheptadine. J. Pharmacol. Exp. Ther.131, 73–84 (1961).
Tasaki, K., U. Tsukahara, S. Ito, M. J. Wayner, andW. Y. Yu: A simple, direct and rapid method for filling microelectrodes. Physiol. and Behav.4, 1009–1010 (1968).
Tebecis, A. K.: Antagonism of 5-hydroxytryptamine by methiothepin shown in microiontophoretic studies of neurons in the lateral geniculate neurons. Nature238, 63–64 (1972).
Thomas, R. C., andV. J. Wilson: Precise localization of Renshaw cells with a new marking technique. Nature (London)206, 211–213 (1965).
Vane, J. R., H. O. J. Collier, S. J. Corne, E. Marley, andP. B. Bradley: Tryptamine receptors in the central nervous system. Nature191, 1068–1069 (1961).
Vargaftig, B. G., J. L. Coignet, C. J. De Vos, H. Grijsen, andI. L. Bonta: Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine. Eur. J. Pharmacol.16, 336–346 (1971).
Winter, J. C.: Behavioral effects of N, N-Dimethyltryptamine: Absence of antagonism by xylamidine tosylate. J. Pharmacol. Exp. Therap.169, 7–16 (1969).
Zernicki, B.: Pretrigeminal cat. Brain Res.9, 1–14 (1968).
Author information
Authors and Affiliations
Additional information
With 3 Figures
Rights and permissions
About this article
Cite this article
Haigler, H.J., Aghajanian, G.K. Peripheral serotonin antagonists: Failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. J. Neural Transmission 35, 257–273 (1974). https://doi.org/10.1007/BF02205223
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02205223